Coherus Oncology, Inc. (CHRS)

Coherus Oncology Revenue

Coherus Oncology had revenue of $12.31M in the quarter ending March 31, 2026, with 61.99% growth. This brings the company's revenue in the last twelve months to $21.83M, up 33.50% year-over-year. In the year 2025, Coherus Oncology had annual revenue of $42.17M with 59.81% growth.

• Revenue (ttm): $21.83M
• Revenue Growth: +33.50%
• P/S Ratio: 4.67
• Revenue / Employee: $323,331
• Employees: 145
• Market Cap: 212.86M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	42.17M	15.78M	59.81%
Dec 31, 2024	26.39M	-230.86M	-89.74%
Dec 31, 2023	257.24M	46.20M	21.89%
Dec 31, 2022	211.04M	-115.51M	-35.37%
Dec 31, 2021	326.55M	-149.27M	-31.37%
Dec 31, 2020	475.82M	119.75M	33.63%
Dec 31, 2019	356.07M	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	1.56M	-188.55M	-99.18%
Dec 31, 2016	190.11M	160.07M	532.82%
Dec 31, 2015	30.04M	-1.07M	-3.42%
Dec 31, 2014	31.11M	28.36M	1,030.72%
Dec 31, 2013	2.75M	852.00K	44.87%
Dec 31, 2012	1.90M	-	-

Data Source: Fiscal.ai Last updated: May 11, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 9, 2026

Data Sources Report a data error